India, March 11 -- The Government of India has issued a release:
The Ministry of Health and Family Welfare (MoHFW), Government of India, has issued a draft Gazette Notification GSR 164(E) dated 9th March 2026, inviting public comments on a proposal to amend Para G (Testing of Blood Products), Part XII C, Schedule F of the Drugs Rules 1945.
The proposed amendment seeks to align regulatory requirements for testing of blood products with internationally accepted pharmacopoeial standards and to remove additional testing requirements on products that are not warranted under global best practices.
As per the official monographs of Human Plasma for Fractionation in the Indian Pharmacopoeia (IP), British Pharmacopoeia (BP), United States Pharmac...